Financials
| Interim results for the six months to 30 June 2025 | Sep. 04, 2025 |
| Results for the year ended 31 December 2024 | Jun. 05, 2025 |
| Interim results for the six months to 30 June 2024 | Sep. 05, 2024 |
| Results for the year ended 31 December 2023 | May. 30, 2024 |
| Interim results for the six months to 30 June 2023 | Aug. 16, 2023 |
| Results for the year ended 31 December 2022 | May. 31, 2023 |
| Interim Results | Sep. 23, 2022 |
Proxies
| Result of AGM | Jun. 30, 2025 |
| Result of AGM | Jun. 27, 2024 |
| Result of AGM and Directorate Change | Jun. 29, 2023 |
| Result of AGM | Apr. 27, 2022 |
| AGM Statement | Apr. 27, 2022 |
| Result of AGM | May. 04, 2021 |
| AGM Statement | May. 04, 2021 |
Ownership Update
| Director Share Purchase | Jun. 13, 2025 |
| Director Share Purchase | Jun. 11, 2025 |
| Director/PDMR Shareholding | Nov. 01, 2024 |
| Holding(s) in Company | Jan. 15, 2024 |
| Holding(s) in Company | Oct. 26, 2022 |
| Holding(s) in Company | Oct. 17, 2022 |
| Director Shareholdings and TVR | Oct. 12, 2022 |
Announcements
| Total Voting Rights | Mar. 31, 2026 |
| Results of Open Offer | Mar. 03, 2026 |
| Open Offer at 0.40p to raise up to £384,408 | Feb. 13, 2026 |
| Update regarding SVV2 | Jan. 15, 2026 |
| Investor Presentations | Jan. 08, 2026 |
| Online Investor Presentation and Q&A Session | Dec. 23, 2025 |
| Issue of Talking Medicines Convertible Loan Notes | Dec. 12, 2025 |